VARANASI: A medicine supply investigation that began in Kurauna village under Jansa police station has led to a second allegedly unlicensed manufacturing unit in Himachal Pradesh, the Uttar Pradesh government said in an update issued on Thursday, November 19, 2026. The new finding concerns a premises at Juddikalan in Baddi. For medicine buyers and distributors in Varanasi, the investigation makes purchase records and the identity of suppliers central to checking the chain through which a product reached them.

The Food Safety and Drug Administration said its inquiry had followed supplies through Lahartara and a storage location in Paramanandpur under Rohaniya police station. The November 19 update describes further manufacturing premises found after a joint operation on November 18. These are the regulator's findings in an ongoing investigation, rather than a court determination of guilt.

Residents seeking a check on a suspect purchase should keep the original strip or carton and the purchase bill, so the product and seller can be identified. The central drug regulator's published rules specify that retail cash or credit memos must carry the dealer's name, address and sale licence number, a memo serial number, and the drug's name and quantity. Those details provide a concrete starting point when raising a purchase query.

What the new official update establishes

The November 19 government release says investigators found another medicine manufacturing operation without a licence at V. D. Pharma in Juddikalan. Equipment for producing tablets, capsules and syrup was found there, along with raw material, partly manufactured products and finished medicines, according to the department.

The material included items associated with the manufacture of antibiotics, antacids and cough syrup. The statement does not supply a total value for the Baddi recovery or a final count of every finished product. It says further statutory action concerning that unit is being taken by Himachal Pradesh's drug department.

  • Latest update: November 19, 2026, with a 5 pm IST footer on the release.
  • First Varanasi premises in the account: Kurauna village, Jansa police station area.
  • Local supply inquiry: Lahartara and Paramanandpur in the Rohaniya area.
  • Joint Himachal operation dated in the release: November 18, 2026.
  • Newly reported additional premises: Juddikalan, Baddi.

How the inquiry moved beyond Varanasi

The release traces the initial action to October 30, when officials inspected a medical store in Kurauna that, they said, was operating without a drug licence. Investigators found tablets being sold under a recognised manufacturer's product name. They contacted the original company, and the department says the company's complaint and a comparative examination confirmed that the recovered tablets were counterfeit.

Officials said other medicines worth about Rs 5 lakh were also seized in that initial action. This figure belongs to the earlier Kurauna recovery. It is not the value of the new Baddi unit or an estimate for the whole investigation. The earlier dates are background to the new November 19 account.

The department says the next local step came on November 2. After questioning people involved in supply and delivery, its team went to a house in Paramanandpur. There, officials reported a stock of 17 kinds of allopathic medicines held without bills or a licence. Eleven samples were taken for examination, and the remaining medicines, valued at about Rs 2 lakh, were seized.

Printing and spelling discrepancies on strips formed part of the officials' suspicions at the storage stage. Sampling and the earlier manufacturer's examination are separate parts of the account. The statement does not provide final laboratory findings for every one of the 11 samples, so the recovery should not be read as a published test result for each medicine.

Manufacturing equipment and further action

According to the release, information obtained after the arrest of an alleged principal supplier led the team towards manufacturing locations in Himachal Pradesh. On November 18, the state drug administration's special team and the Uttar Pradesh Special Task Force carried out a joint operation at an identified unit in the Rajpura Khera bypass area of Nalagarh tehsil, Solan district.

The department reported blister packing, capsule filling and other packaging equipment there, together with printed foil and printing material. It says investigators were examining how products carrying branded medicine names were manufactured and moved into the market. The subsequent Juddikalan finding extends that inquiry to another premises.

The release also says investigators identified leads in Saharanpur concerning manufacture, storage and purchase or sale of medicines. Proceedings to register a further case were being pursued there. It does not report a final statewide distribution list, an identified number of affected patients or a completed assessment of harm.

What residents should do

Keep the bill and packaging together when asking for verification of a particular purchase. A product name appearing in an investigation does not identify every batch in circulation. The central regulator's published record requirements explain why the seller's licence details and the transaction record matter when tracing supply.

For separate local healthcare background, readers can use the Varanasi hospital guide, the earlier BHU health fair report and the report on recent BHU valve procedures. Those reports concern other healthcare services and are not evidence in this medicine investigation.